Outcomes
SECONDARY
The primary outcome was the mean number of central nervous system (CNS)-active medications per resident per month, with the primary endpoint for analysis being 6 months post-intervention. CNS-active medications included antipsychotics, opioids, benzodiazepines, and antidepressants (including tricyclic antidepressants and trazodone), consistent with the indicator used in the OH report. We selected this as the primary outcome to enable us to capture any prescribing changes directly influenced by the report indicators. We planned to assess antipsychotic and benzodiazepine prescriptions as secondary outcomes, as well as statin prescriptions (as a non-targeted control or “tracer outcome” [